Health Care/Hospital News & Press Release Distribution

Sea trial completed for hospital ship Global Mercy

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Stena RoRo is leading the project for the construction of the Global Mercy™, the world's largest civilian hospital ship. After several years of construction at the Tianjin Xingang shipyard in northernChina, the final test, the official sea trial, has now be...

2021-05-10 13:51 1321

CAPA-IVM a promising advance in assisted reproduction for women with PCOS

SINGAPORE, May 10, 2021 /PRNewswire/ -- The first births and on-going well-being of babies born from an advanced assisted reproduction process called CAPA in-vitro oocyte maturation, or IVM, has highlighted the potential of the procedure for millions of women with complex fertility issues includi...

2021-05-10 13:00 1785

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 11:30 1191

New focus on male factors critical for success in human fertility treatment

SINGAPORE, May 10, 2021 /PRNewswire/ -- The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE Congress, originally to be held in the Philippine...

2021-05-10 10:06 1262

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 10:00 1357

Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 09:36 2700

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1485

Improving access and affordability of fertility treatment in low to middle income countries

SINGAPORE, May 8, 2021 /PRNewswire/ -- Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). Countries including Indo...

2021-05-08 15:09 2538

Aaseya Receives the Client Innovation Award for Social Responsibility from Pega

HYDERABAD, India, May 8, 2021 /PRNewswire/ -- Aaseya, Pega Gold Partner, received the Client Innovation Award for Social Responsibility from Pegasystems atPegaWorld iNspire 2021 . This prestigious award from Pega recognizes Aaseya for the excellence in deliv...

2021-05-08 01:47 3332

Daewoong showed improved performance both sales and earnings in Q1

* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...

2021-05-07 21:00 4484

Clarivate Announces 2020 Revenue Cycle Awards Recipients

Winners of the annual award include ThedaCare Regional Medical Center, University of Iowa Hospitals & Clinics and Essentia Health LONDON, May 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, to...

2021-05-07 20:00 5641

Clarivate Announces 2020 Revenue Cycle Awards Recipients

Waterdrop Inc. Announces Pricing of Initial Public Offering

BEIJING, May 7, 2021 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced the pricing of its initial public offering ("IPO") of 30,000,000 American depositary shar...

2021-05-07 18:00 4542

UserTesting Research Finds Australians Express Caution Regarding Travel Bubble, and For Good Reason

SYDNEY, May 7, 2021 /PRNewswire/ -- Optimism abounded for many Australian tourists when a travel bubble betweenAustralia and New Zealand, allowing travel without quarantine, opened onApril 18th. UserTesting , a leading provider of on-demand Human Insights

2021-05-07 16:47 2088

Vakrangee Enters The Online Space With The Launch Of Digital Services

- Through this, company has evolved into the unique O2O (Online to Offline) platform, whereby there is Assistance available through the 10,000+ Physical Kendra store network along with Digital Online Services - Initiated this Unique Hybrid proposition with launch of first Digital service of Tele...

2021-05-07 14:08 3437

COVID Vaccine-Hesitant Consumers Care About Effectiveness Over Side-Effects

SYDNEY, May 7, 2021 /PRNewswire/ -- Market research software company Conjoint.ly today released results from its recentConsumer Preferences for COVID-19 Vaccine conjoint analysis survey, revealing that vaccine-hesitant consumers in the UK and US are most likely to be swayed by a fully-subsidised ...

2021-05-07 12:15 1741

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal,Germany, the Pfizer China ("Pfizer") manufacturing...

2021-05-07 08:30 4528

The Biofactory To Convert Hospital Facilities Into Isolation Facilities Under Master Agreement Signed

SINGAPORE, May 7, 2021 /PRNewswire/ -- The Biofactory has signed a master supply and servicing agreement with ALPS Pte. Ltd, the public healthcare supply chain agency, to be able to provide portable prefabricated negative pressure anterooms to local public healthcare and research institutions etc...

2021-05-07 08:05 2565

No More Lining up for Flu Shots, Experience Innovative Service Flow Design at Xizhi District Pubic Health Center

TAIPEI, May 7, 2021 /PRNewswire/ -- Taiwan Design Research Institute (TDRI) cooperates with New Taipei City Department of Health for the "Public Health Center Re-Designed" project, hoping to make use of design to turn the image and service efficiency of public health institutions around. InTaiwan...

2021-05-07 08:00 1991

No More Lining up for Flu Shots, Experience Innovative Service Flow Design at Xizhi District Pubic Health Center

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo Therapeutics Inc., a U.S. new drug developer, as its first investment destination. RosVivo recently developed RSVI-301, a new d...

2021-05-07 07:00 3639

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

The world's first-in-class miRNA therapeutics to cure diabetes by pancreatic beta cell regeneration

SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to expand its new bio business. Nexturn Bio announced that it has secured a 50% stake in RosVivo Therapeutics, Inc....

2021-05-07 07:00 2851